Abstract

Adoptive transfer of specific cytotoxic T lymphocytes (CTL) and Cytokine Induced Killer Cells (CIK) following genetic engineering of T-cell receptor zeta hold promising perspective in immunotherapy. In the present work we focused on the mechanisms of anti-tumor action of effectors transduced with an anti-CD19 chimaeric receptor in the context of B-lineage acute lymphoblastic leukemia (B-ALL). Primary B-ALL blasts were efficiently killed by both z-CD19 CTL and z-CD19 CIK effectors. The use of death receptor mediated apoptosis of target cells was excluded since agonists molecules of Fas and TRAIL-receptors failed to induce cell death. Perforin/granzyme pathway was found to be the mechanism of chimaeric effectors mediated killing. Indeed, cytolytic effector molecules perforin as well as granzymes were highly expressed by CTL and CIK. CD19 specific stimulation of transduced effectors was associated with degranulation as attested by CD107 membrane expression and high IFN-γ and TNF-α release. Moreover inhibitors of the perforin-based cytotoxic pathway, Ca2+-chelating agent EGTA and Concanamycin A, almost completely abrogated B-ALL blast killing. In conclusion we show that the cytolysis response of z-CD19 chimaeric effectors is predominantly mediated via perforin/granzyme pathway and is independent of death receptors signaling in primary B-ALL.

Highlights

  • Allogeneic hematopoietic stem cell transplantation constitutes the main curative treatment of hematological malignancies and disorders

  • In the present work we show that tumor killing by cytotoxic T lymphocytes (CTL) and CIK cells transduced with zeta-CD19 receptor is predominantly mediated via the perforin/granzyme pathway and is independent of death receptors signaling in primary B-lineage acute lymphoblastic leukemia (B-ALL)

  • CTL anti-EBV and CIK cells transduced with zeta-CD19 receptor were controlled and were similar to our previous publications

Read more

Summary

Introduction

Allogeneic hematopoietic stem cell transplantation constitutes the main curative treatment of hematological malignancies and disorders. The potency of the graft versusleukemia effect varies widely depending on the type of leukemia. For B-lineage acute lymphoblastic leukemia (BALL), the graft versus-leukemia effect is modest and disease relapse after transplantation is a major contributor to treatment failure [1]. Adoptive cellular therapy such as donor lymphocyte infusions achieves poor remission rates in patients with BALL and is associated with a high incidence and severity of graft-versus-host disease morbidity and mortality [2]. Adoptive immunotherapy targeting chosen antigens selectively expressed by leukaemic targets should separate graft-versusleukemia and graft-versus-host disease. Chimaeric receptors are generated by joining the heavy and light chain variable regions of a monoclonal antibody, expressed as a single-chain Fv molecule, to the cytoplasmic T-cell receptor zeta [3]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call